Literature DB >> 23706828

Development of a quantitative immunofluorescence assay for detection of Stenotrophomonas maltophilia antibodies in patients with cystic fibrosis.

P Gonçalves Vidigal1, D Schmidt, F Stehling, U Mellies, E Steinmann, J Buer, P-M Rath, J Steinmann.   

Abstract

BACKGROUND: To describe a simple quantitative immunofluorescence assay (IFA) for the detection of specific Stenotrophomonas maltophilia antibodies in serum of CF patients.
METHODS: A total of 100 sera (64 CF patients and 36 healthy subjects) were collected over a period of 2 years at the University Hospital Essen, Germany. Sputum culture status classified CF patients into groups. Serologic response was determined after Pseudomonas aeruginosa absorption by indirect IFA to Sm whole cell.
RESULTS: CF patients with "chronic S. maltophilia" showed significantly higher S. maltophilia antibody levels compared with healthy individuals (P<0.0001) and CF patients with "intermittent" (P=0.0315) or "never S. maltophilia/P. aeruginosa" (P=0.0002). A discriminant cut-off value of >1:120 titre was established to differentiate "CF chronic S. maltophilia" from the other groups. For "CF chronic S. maltophilia", the IFA showed sensitivity and specificity values of 70.7% and 84.7%, respectively.
CONCLUSION: Our data demonstrated that quantitative IFA is a simple serological assay for the detection of specific S. maltophilia antibodies, which could be useful as a diagnostic tool for monitoring immune response of CF patients to S. maltophilia.
Copyright © 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis; Immune response; S. maltophilia

Mesh:

Substances:

Year:  2013        PMID: 23706828     DOI: 10.1016/j.jcf.2013.04.011

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  5 in total

1.  Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study.

Authors:  Joerg Grosse-Onnebrink; Florian Stehling; Eva Tschiedel; Margarete Olivier; Uwe Mellies; Rene Schmidt; Jan Buer; Peter-Micheal Rath; Joerg Steinmann
Journal:  BMC Pulm Med       Date:  2017-06-29       Impact factor: 3.317

2.  Insights into Cystic Fibrosis Polymicrobial Consortia: The Role of Species Interactions in Biofilm Development, Phenotype, and Response to In-Use Antibiotics.

Authors:  Andreia P Magalhães; Susana P Lopes; Maria O Pereira
Journal:  Front Microbiol       Date:  2017-01-13       Impact factor: 5.640

3.  Antibacterial Activity of the Novel Drug Gepotidacin against Stenotrophomonas maltophilia-An In Vitro and In Vivo Study.

Authors:  Maike Isabell Sanders; Eyhab Ali; Jan Buer; Joerg Steinmann; Peter-Michael Rath; Hedda Luise Verhasselt; Lisa Kirchhoff
Journal:  Antibiotics (Basel)       Date:  2022-02-01

4.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

5.  Analysis of Phylogenetic Variation of Stenotrophomonas maltophilia Reveals Human-Specific Branches.

Authors:  Joerg Steinmann; Uwe Mamat; Ebrahim M Abda; Lisa Kirchhoff; Wolfgang R Streit; Ulrich E Schaible; Stefan Niemann; Thomas A Kohl
Journal:  Front Microbiol       Date:  2018-04-26       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.